Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05690451

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

Conditions: Hepatocellular Carcinoma

Sex: All
Ages: 20 Years – 85 Years
Enrollment: 210
Sponsor: Seoul National University Hospital

Location: Korea, Republic of

Summary

This prospective multicenter study aimed to compare the diagnostic performance of non-contrast abbreviated MRI in detecting recurrent HCC after curative treatment to that of contrast-enhanced liver CT.

Eligibility Criteria

Inclusion Criteria:Age between 20-year old and 85-year oldPatients with a history of curative treatment for HCC including surgical resection or local ablationNo recurrence after curative treatment of HCC for more than two yearsPatient who has the plan to perform contrast-enhanced liver CT for secondary surveillance for HCC (i.e., to detect de novo or recurrent HCC)Exclusion Criteria:Estimated GFR less than 60Previous history of severe allergic reaction to the iodinated contrast agentPatients with claustrophobia who can't undergo MR examinationPatients having cochlear implants or cardiac pacemaker

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05690451). StuddyBuddy aggregates publicly available trial information.